Comparative Cost‐Effectiveness of First‐Line Immunotherapy‐Based Regimens for Advanced Triple‐Negative Breast Cancer
Year: 2026
Type: article
DOI: 10.1111/jebm.70184
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
Award: G1011884023
OpenAlex ID: W7203675502
